Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study (Q41437823)

30 September 2017

Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study (English)

1 reference

30 September 2017

1 reference

1 reference

5

1 reference

30 September 2017

3

Inger Johanne Bakken

0 references

Ted Reichborn-Kjennerud

series ordinal

9

object named as

Ted Reichborn-Kjennerud

1 reference

30 September 2017

2

Gun Peggy Knudsen

1 reference

30 September 2017

6

Pål Surén

1 reference

30 September 2017

1

Ragnar Nesvåg

0 references

Camilla Stoltenberg

series ordinal

8

object named as

Camilla Stoltenberg

1 reference

30 September 2017

4

Anne Høye

1 reference

30 September 2017

Ragnar Nesvåg

1

1 reference

PubMed ID

25680837

30 September 2017

Anne Reneflot

series ordinal

7

1 reference

30 September 2017

14 February 2015

1 reference

30 September 2017

10

1 reference

Social Psychiatry and Psychiatric Epidemiology

inferred from page(s)

published in

1 reference

30 September 2017

50

1 reference

30 September 2017

1267-1276

1 reference

30 September 2017

8

1 reference

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

30 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Impact of persistent substance misuse on 1-year outcome in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Substance misuse in patients with schizophrenia: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Prevalence of alcohol use disorders in schizophrenia--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

The prevalence and significance of substance use disorders in bipolar type I and II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

A Norwegian psychiatric epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Mental illness in a rural area: a Norwegian psychiatric epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Limitations of the Application of Fourfold Table Analysis to Hospital Data

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

21 January 2018

12 December 2020

Comorbid mental disorders: implications for treatment and sample selection

2 references

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

21 January 2018

12 December 2020

Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Classification of bipolar disorder in psychiatric hospital. A prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Reliability of clinical ICD-10 schizophrenia diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Young cases of schizophrenia identified in a national inpatient register--are the diagnoses valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

The validity of schizophrenia diagnosis in the Finnish Hospital Discharge Register: findings from a 10-year birth cohort sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-015-1025-2

Clinical aspects of substance abuse in persons with schizophrenia

21 January 2018

1 reference

12 December 2020

Models of comorbidity for multifactorial disorders.

1 reference

12 December 2020

Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

1 reference

12 December 2020

Substance abuse in first-episode non-affective psychosis

1 reference

12 December 2020

10.1007/S00127-015-1025-2

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

25680837